ABL1 Is a Prognostic Marker and Associated with Immune Infiltration in Hepatocellular Carcinoma

Table 1

Association between ABL1 expression and clinicopathological characteristics in the TCGA HCC cohort.

Variable	Low ABL1 expression (n = 170)	High ABL1 expression (n = 171)	X^2	value
Age			0.8026	0.3703
≤50	33	40
>50	137	131
Gender			6.6817	<0.01
Female	49	80
Male	121	111
TNM stage			3.1116	0.119
I/II	124	114
III/IV	46	57
Histologic grade			6.1729	0.013
G1/G2	123	91
G3/G4	47	80
Survival status
Alive	113	105	48.0403	<0.01
Dead	57	66